Chicago Partners Investment Group LLC

Position in NRXP — NRX Pharmaceuticals, Inc.

CIK 1563525 CHICAGO, IL

Back to NRXP Full portfolio

Position in NRXP

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$189,726

+$116,286 QoQ

Shares Held

46,388

+34.5% QoQ

Ownership

0.107%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#18

of 47 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Common Shares in NRXP Over Time

Shares Held

Position Value (USD)

Derivatives in NRXP

reported options exposure · as of Mar 31, 2026

CallValue

$1,065

CallShares

500

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Chicago Partners Investment Group LLC holds $16,750,273 across 43 Biotechnology names. NRXP ranks #27 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TSHA	Taysha Gene Therapies, Inc.	222,347	$1,514,183
2	REGN	Regeneron Pharmaceuticals, Inc.	2,209	$1,377,399
3	JAZZ	Jazz Pharmaceuticals plc	5,326	$1,283,406
4	VRTX	Vertex Pharmaceuticals Inc / Ma	2,455	$1,219,472
5	CING	Cingulate Inc.	188,429	$1,030,706
6	EXEL	Exelixis, Inc.	18,752	$1,020,296
7	RPRX	Royalty Pharma plc	14,923	$836,732
8	BMRN	Biomarin Pharmaceutical Inc	12,109	$692,876

All Filings in NRXP

Export CSV

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$189,726	46,388	+34.5%	Shares	Sole	2026-07-30
2026-03-31	$73,440	34,479	+3.2%	Shares	Sole	2026-05-04
2026-03-31	$1,065	500	—	Call	Sole	2026-05-04
2025-12-31	$90,570	33,421	-20.4%	Shares	Sole	2026-01-28
2025-09-30	$138,580	41,994	—	Shares	Sole	2025-10-30
No filing history on record for this holder in this stock.